Corcept Therapeutics Inc. (CORT) reported a net loss of $7.6 million or $0.09 per share for the second quarter compared to the loss of $8.9 million or $0.11 per share last year.
Net product sales for the three-month period stood flat at $875 thousand.
Analysts polled by Thomson Reuters expected the company to report a loss of $0.11 per share on revenues of $1.82 million for the quarter. Analysts' estimates typically exclude special items.
For comments and feedback: editorial@rttnews.com